Family PracticeNursingPulmonologyInternal MedicineCritical CareEmergency MedicineNephrologyGeriatricsConditionsKidney ProblemsInfectious DiseaseCoronavirus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Sept. 8, 2020 (HealthDay News) -- Acute kidney injury (AKI) is common in hospitalized patients with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 3 in the Journal of the American Society of Nephrology.
Lili Chan, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a retrospective observational study involving hospitalized patients with laboratory-confirmed COVID-19. The frequency of AKI and outcomes were examined for 3,993 hospitalized patients.
The researchers found that AKI occurred in 46 percent of the patients, and 19 percent of those with AKI required dialysis. Of those with AKI, 39, 19, and 42 percent of patients had stages 1, 2, and 3 AKI, respectively. Overall, 24 percent of patients were admitted to the intensive care unit; 76 percent of these patients experienced AKI. Of the 435 patients with AKI and urine studies, 84, 81, and 60 percent had proteinuria, hematuria, and leukocyturia, respectively. Chronic kidney disease, male gender, and higher serum potassium at admission were independent predictors of severe AKI. In-hospital mortality was 50 and 8 percent among those with and without AKI, respectively (adjusted odds ratio, 9.2). Thirty-five percent of survivors with AKI who were discharged had not recovered to baseline kidney function by the time of discharge.
"The sheer number of AKI cases, and the overwhelming need for dialysis that we are seeing in the context of COVID-19, is unprecedented," a coauthor said in a statement. "These findings may help health systems prepare for the high rates of renal dysfunction in incoming COVID-19 patients."
Several authors disclosed financial ties to the pharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 25, 2022
Read this Next
Other Trending Articles